Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization 2023-06-07 16:05
Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX 2023-06-07 12:29
BetaLife wins Cytiva's first BioChallenge Competition in Southeast Asia 2023-06-07 12:00
LiveSpo represents Vietnam to announce the world's first spore probiotics in nasal spray form at the BIO International Convention 2023-06-06 19:40
Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting 2023-06-06 09:06
Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting 2023-06-06 08:00
ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer 2023-06-05 21:26
RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name 2023-06-05 21:17
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure 2023-06-05 21:00
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing 2023-06-05 20:00
ISCT 2023: Late-breaking SCG101 Data Show 100% HBsAg+ Hepatocyte Eradication and 74.5% HCC Tumour Reduction With Single Dose HBsAg-specific TCR-T Cell Therapy 2023-06-05 10:28
Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting 2023-06-05 08:00
Turn Biotechnologies Founder to be Featured Speaker at Japanese Society of Anti-Aging Medicine Meeting 2023-06-05 08:00
Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting 2023-06-04 08:36
Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST 2023-06-03 07:59
Anti- Ageing and Reproductive Medical Giants to Gather in Hong Kong, Dragon's Medical Leads Chinese Medical Development 2023-06-02 23:02
Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference. 2023-06-02 19:14
Latest Updates of 9 Viva's Portfolio Companies 2023-06-02 18:51
Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research 2023-06-02 18:00
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China 2023-06-02 08:00
1 35 36 37 38 39 216